D. Leary - Concepedia

Author

D. Leary

Princess Alexandra Hospital

Also Known As

D LEARY, D Leary, D. Leary, D. R. Leary, DIANA R LEARY, Diana Leary, Diana R. Leary, Leary, D.

Publications

388

Citations

H-Index

Concepts

All Affiliations

Princess Alexandra Hospital The University of Queensland Royal Brisbane and Women's Hospital Kidney Health Australia Translational Research Institute

About

D. Leary is an author at Princess Alexandra Hospital specializing in medicine, transplantation, and kidney transplant.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	146
2	Nephrology	2	2	88
3	Kidney Transplant	2	2	88
4	Transplantation	2	2	88
5	Cancer Research	1	1	58

D. Leary

Publications

378

Citations

H-Index

Page 1

	Year	Citations
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial Michael G. Collins, Magid Fahim, Elaine M. Pascoe, The Lancet TransplantationKidney TransplantKidney TransplantationTransplantation MedicineOrgan Preservation	2023	69
Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia Michelle R. Iannacone, Sudipta Sinnya, Nirmala Pandeya, Journal of Investigative Dermatology Liver Transplant RecipientsMedicineRelated Skin TumorsDermatologyOncology	2016	58
Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients Katherine A. Barraclough, Nicole M. Isbel, Carl M. J. Kirkpatrick, British Journal of Clinical Pharmacology	2010	49
NR1I2 Polymorphisms Are Related to Tacrolimus Dose-Adjusted Exposure and BK Viremia in Adult Kidney Transplantation Katherine A. Barraclough, Nicole M. Isbel, Katie J. Lee, Transplantation	2012	46
Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week Katherine A. Barraclough, Christine E. Staatz, David W. Johnson, Transplant International	2012	44
A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial Katherine A. Barraclough, Fiona G. Brown, Carmel M. Hawley, Nephrology Dialysis Transplantation	2012	35
Detection of Recently Discovered Human Polyomaviruses in a Longitudinal Kidney Transplant Cohort Seweryn Bialasiewicz, Rebecca J. Rockett, Katherine A. Barraclough, American Journal of Transplantation	2016	23
A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients Katherine A. Barraclough, Nicole M. Isbel, David W. Johnson, Nephrology	2011	21
Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients Katherine A. Barraclough, Nicole M. Isbel, Brett McWhinney, European Journal of Clinical Pharmacology UrologyTransplantationKidney TransplantKidney TransplantationSolid Organ Transplantation	2011	19
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial) Katherine A. Barraclough, Euan Noble, D. Leary, BMC Nephrology	2009	14

Page 1